Equifax Inc
NYSE:EFX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
204.0415
280.0075
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
EFX
stock under the Base Case scenario is
200.91
USD.
Compared to the current market price of 211.51 USD,
Equifax Inc
is
Overvalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Equifax Inc.
| UK |
|
Relx PLC
LSE:REL
|
|
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
|
| UK |
I
|
IHS Markit Ltd
F:0M3
|
|
| IE |
|
Experian PLC
LSE:EXPN
|
|
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
|
| US |
|
CoStar Group Inc
NASDAQ:CSGP
|
|
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
|
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
|
| CH |
|
SGS SA
SIX:SGSN
|
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Continued fallout from data breaches and high-profile security incidents could erode Equifax’s reputation and prompt stricter regulatory oversight, potentially leading to higher compliance costs and difficulty winning new client trust.
Rapid changes in consumer lending dynamics and the emergence of alternative credit-scoring models (including proprietary bank-led initiatives) may diminish Equifax’s traditional data business, limiting its pricing power and market share.
International expansion risks loom large, as regional data-privacy regulations and political pressures could hamper Equifax’s growth abroad, requiring substantial investment to adapt or risking reduced profitability.
Equifax’s proprietary data assets, combined with its advanced analytics platforms, remain the backbone of many consumer lending decisions, ensuring a steady flow of high-margin business and reinforcing its competitive moat.
Growing demand for enhanced cybersecurity and identity verification services provides a promising avenue for Equifax’s new product offerings, leveraging its brand recognition in financial services to cross-sell solutions to existing clients.
Strong partnerships with major financial institutions and stable recurring revenues from credit monitoring subscriptions position Equifax for long-term, predictable cash flows, supporting ongoing investments in innovation and technology upgrades.
Revenue & Expenses Breakdown
Equifax Inc
Balance Sheet Decomposition
Equifax Inc
| Current Assets | 1.5B |
| Cash & Short-Term Investments | 189m |
| Receivables | 1B |
| Other Current Assets | 259.1m |
| Non-Current Assets | 10.4B |
| PP&E | 1.9B |
| Intangibles | 8.1B |
| Other Non-Current Assets | 324.3m |
| Current Liabilities | 2B |
| Accounts Payable | 156.2m |
| Accrued Liabilities | 544.1m |
| Short-Term Debt | 81.5m |
| Other Current Liabilities | 1.2B |
| Non-Current Liabilities | 4.9B |
| Long-Term Debt | 4.1B |
| Other Non-Current Liabilities | 856m |
Free Cash Flow Analysis
Equifax Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Equifax Inc
|
Revenue
|
5.9B
USD
|
|
Cost of Revenue
|
-2.6B
USD
|
|
Gross Profit
|
3.3B
USD
|
|
Operating Expenses
|
-2.1B
USD
|
|
Operating Income
|
1.2B
USD
|
|
Other Expenses
|
-538.3m
USD
|
|
Net Income
|
658.6m
USD
|
EFX Profitability Score
Profitability Due Diligence
Equifax Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Equifax Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
EFX Solvency Score
Solvency Due Diligence
Equifax Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Equifax Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EFX Price Targets Summary
Equifax Inc
According to Wall Street analysts, the average 1-year price target for
EFX
is 272.11 USD
with a low forecast of 241.39 USD and a high forecast of 315 USD.
Dividends
Current shareholder yield for
EFX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EFX
stock under the Base Case scenario is
200.91
USD.
Compared to the current market price of 211.51 USD,
Equifax Inc
is
Overvalued by 5%.